Skip to Main content Skip to Navigation
Journal articles

Change in the regulatory framework for zolpidem

Abstract : In recent years, zolpidem has been the subject of numerous reports of misuse, abuse and dependence. In view of these risks, the French drug agency (ANSM) decreed in April 2017 the implementation of secure prescription pads. The objective of this study was to evaluate the impact of this regulatory measure on the prescription of zolpidem and other sedative medications (zopiclone, benzodiazepines and antihistamines) in long-term users of zolpidem and associated factors.
Document type :
Journal articles
Complete list of metadata
Contributor : Martine Augouvernaire Connect in order to contact the contributor
Submitted on : Thursday, October 28, 2021 - 11:21:06 AM
Last modification on : Wednesday, May 25, 2022 - 4:34:02 PM



Marion Istvan, Pascal Caillet, Morgane Rousselet, Marylène Guerlais, Edouard-Jules Laforgue, et al.. Change in the regulatory framework for zolpidem. British Journal of Clinical Pharmacology, Wiley, 2021, 87 (8), pp.3310-3319. ⟨10.1111/bcp.14753⟩. ⟨hal-03407064⟩



Record views